We create value.
aXichem is an innovative biotechnology company specialising in development of natural analogue ingredients.
aXichem has been complying with Article 19 of the MarketAbuse Regulation (MAR) since 3 July 2016 in respect of the obligation of people in managerial positions (insiders), and persons closely related to them, to report changes in their shareholdings to Finansinspektionen [the Swedish Financial Supervisory Authority]. The reporting of changes in shareholders notified by insiders at aXichem is available on Finansinspektionen’s website: Insynsregister